glp-1 patches efficacy Patches: Do They Work? GLP-1 Patches? : r/glp1

The FDA granted accelerated approval in August 2025 for a new GLP-1-related indication, and the 2026 American Diabetes Association Standards of Care now recommend GLP-1 receptor agonists as preferred agents for specific patient groups

Discussion In this large national cohort study of patients with MASLD and diabetes but without cirrhosis, we observed protective associations between GLP-1 RA use and subsequent development of cirrhosis, cirrhosis complications, and overall mortality

Growth Drivers & Trends Trends anticipated to further drive growth in the sterile fill-finish space include self-administered therapies and drug device combination products, long-acting therapies, complex biologics, and more resilient supply chains

She was receiving tirzepatide 2.5 mg weekly, then titrated to 5 mg after one month, and this dose was maintained for over a year